GeoVax Labs

GOVX

GeoVax is a clinical-stage biotechnology company which develops vaccines. GeoVax's development platform uses Modified Vaccinia Ankara (MVA) vector technology, with improvements to antigen design and manufacturing capabilities. GeoVax uses recombinant DNA or recombinant viruses to produce virus-like particles (VLPs) in the person being vaccinated.

GeoVax Labs has been a target of short sellers for a while. The current short interest of 2.67% is slightly below the average of the last 12 months (6.84%).